|
| 38091020 | Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era. | JAMA Surg | 2024 |
| 38091020 | Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era. | JAMA Surg | 2024 |
| 36380012 | Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers. | Breast Cancer Res Treat | 2023 |
| 36380012 | Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers. | Breast Cancer Res Treat | 2023 |
| 37728516 | Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers. | Cancer Prev Res (Phila) | 2023 |
| 37022294 | Endometrial safety of low-dose vaginal estrogens. | Menopause | 2023 |
| 36892725 | Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay. | Breast Cancer Res Treat | 2023 |
| 37141817 | Detection of endometrial cancer using tampon-based collection and methylated DNA markers. | Gynecol Oncol | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37259802 | Reproductive Events and Risk of Women's Cancers: From Parturition to Prevention. | Cancer Prev Res (Phila) | 2023 |
| 36922547 | Short-term changes in ultrasound tomography measures of breast density and treatment-associated endocrine symptoms after tamoxifen therapy. | NPJ Breast Cancer | 2023 |
| 36790339 | Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 36596665 | Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort. | Cancer Prev Res (Phila) | 2023 |
| 37728516 | Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers. | Cancer Prev Res (Phila) | 2023 |
| 37259802 | Reproductive Events and Risk of Women's Cancers: From Parturition to Prevention. | Cancer Prev Res (Phila) | 2023 |
| 37022294 | Endometrial safety of low-dose vaginal estrogens. | Menopause | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37141817 | Detection of endometrial cancer using tampon-based collection and methylated DNA markers. | Gynecol Oncol | 2023 |
| 36790339 | Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 36922547 | Short-term changes in ultrasound tomography measures of breast density and treatment-associated endocrine symptoms after tamoxifen therapy. | NPJ Breast Cancer | 2023 |
| 36596665 | Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort. | Cancer Prev Res (Phila) | 2023 |
| 36892725 | Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay. | Breast Cancer Res Treat | 2023 |
| 34810211 | Molecular and Clinical Characterization of Postpartum-Associated Breast Cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 36375388 | Reproductive risk factors associated with breast cancer in young women by molecular subtype. | Breast | 2022 |
| 35583138 | Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer. | JNCI Cancer Spectr | 2022 |
| 35507180 | Protocol for the Detection of Organoid-Initiating Cell Activity in Patient-Derived Single Fallopian Tube Epithelial Cells. | Methods Mol Biol | 2022 |
| 35821041 | Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence. | Breast Cancer Res | 2022 |
| 35503494 | Serum hormone levels and normal breast histology among premenopausal women. | Breast Cancer Res Treat | 2022 |
| 36347887 | Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer. | NPJ Breast Cancer | 2022 |
| 35875052 | DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model. | NAR Cancer | 2022 |
| 35370009 | Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility. | Gynecol Oncol | 2022 |
| 35801929 | Response to Mitr and Pollack. | J Natl Cancer Inst | 2022 |
| 35776497 | Distinctions in PCOS Induced by Letrozole Vs Dehydroepiandrosterone With High-fat Diet in Mouse Model. | Endocrinology | 2022 |
| 35299252 | Lower Exome Sequencing Coverage of Ancestrally African Patients in The Cancer Genome Atlas. | J Natl Cancer Inst | 2022 |
| 35046392 | Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning. | NPJ Breast Cancer | 2022 |
| 35333343 | Association of Genetic Ancestry With Terminal Duct Lobular Unit Involution Among Healthy Women. | J Natl Cancer Inst | 2022 |
| 35216968 | Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study. | Am J Obstet Gynecol | 2022 |
| 35160244 | Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography. | J Clin Med | 2022 |
| 34756471 | The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workup. | Gynecol Oncol | 2022 |
| 34810211 | Molecular and Clinical Characterization of Postpartum-Associated Breast Cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35583138 | Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer. | JNCI Cancer Spectr | 2022 |
| 35507180 | Protocol for the Detection of Organoid-Initiating Cell Activity in Patient-Derived Single Fallopian Tube Epithelial Cells. | Methods Mol Biol | 2022 |
| 35801929 | Response to Mitr and Pollack. | J Natl Cancer Inst | 2022 |
| 35503494 | Serum hormone levels and normal breast histology among premenopausal women. | Breast Cancer Res Treat | 2022 |
| 35370009 | Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility. | Gynecol Oncol | 2022 |
| 35821041 | Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence. | Breast Cancer Res | 2022 |
| 35776497 | Distinctions in PCOS Induced by Letrozole Vs Dehydroepiandrosterone With High-fat Diet in Mouse Model. | Endocrinology | 2022 |
| 35875052 | DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model. | NAR Cancer | 2022 |
| 36347887 | Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer. | NPJ Breast Cancer | 2022 |
| 36375388 | Reproductive risk factors associated with breast cancer in young women by molecular subtype. | Breast | 2022 |